Sugammadex vs. Neostigmine in Laparoscopic Prostatectomy Sugammadex vs. Neostigmine in Laparoscopic Prostatectomy
Can sugammadex reduce the length of hospital stay, recovery time, and unplanned readmission for patients who underwent robot-assisted laparoscopic prostatectomy when compared to neostigmine?BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Better Continence Rate Gives Robotic Prostatectomy the Edge Better Continence Rate Gives Robotic Prostatectomy the Edge
Rates of urinary continence were higher after robot-assisted radical prostatectomy than after laparoscopic radical prostatectomy in a large-scale, randomized comparison of the two approaches.Medscape Medical News (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 5, 2020 Category: Surgery Tags: Urology News Source Type: news

Roche ’s IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone met one of its co-primary endpoints
      ·Phase III IPATential150 study evaluating ipatasertib in combination with abiraterone and prednisone/prednisolone compared to current standard-of-care (abiraterone and prednisone/prednisolone alone) plus placebo met its co-primary endpoint of radiographic progression free survival (rPFS) in patients with PTEN loss tumoursBasel, 19 June 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the phase III IPATential150 study met its co-primary endpoint of radiographic progression-free survival (rPFS) in patients with metastatic castration-resistant prostate cancer (mCR...
Source: Roche Media News - June 19, 2020 Category: Pharmaceuticals Source Type: news

Genomic Prostate Score Does Not Improve Risk Assessment Genomic Prostate Score Does Not Improve Risk Assessment
A genomic prostate score has little value in predicting adverse outcomes in men who have undergone a period of active surveillance before having a radical prostatectomy, according to a study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 25, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

NCCN Guidelines Designate Decipher Prostate as "Recommended" for Men with Adverse Pathology after Radical Prostatectomy
The first and only genomic test to achieve "Recommended" status for the management of prostate cancer patients SAN DIEGO, March 24, 2020 -- (Healthcare Sales & Marketing Network) -- Decipher Biosciences, a commercial-stage precision oncology ... Diagnostics, Urology, Oncology Decipher Biosciences, Decipher Prostate RP, prostate cancer, NCCN (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 24, 2020 Category: Pharmaceuticals Source Type: news

Prostatectomy, Radiotherapy Effective Primary Treatments for Prostate Cancer Prostatectomy, Radiotherapy Effective Primary Treatments for Prostate Cancer
Radical prostatectomy (RP) and radiotherapy (RT) are good primary treatment options for men with high-risk localized and locally advanced prostate cancer, according to a systematic review.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 19, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Web-Based Tool Helps Predict Functional Outcomes After Prostate Cancer Treatment Web-Based Tool Helps Predict Functional Outcomes After Prostate Cancer Treatment
A web-based tool can help predict functional outcomes for five years after treatment of localized prostate cancer with radical prostatectomy (RP), intensity-modulated radiation therapy (RT), or active surveillance, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - March 18, 2020 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Prostatectomy of Mixed Mortality Benefit in Men With Cancer Prostatectomy of Mixed Mortality Benefit in Men With Cancer
Over decades, death from any cause is lower in some men who undergo radical prostatectomy but observation alone may be a better choice in others with prostate cancer, according to a long-term follow-up of a randomized trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 12, 2020 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Surgical Approach Not Tied to Decision Regret After Prostatectomy
Functional and oncologic outcomes, autonomous decision - making, and follow - up time influence regret (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 3, 2020 Category: Cancer & Oncology Tags: Oncology, Surgery, Urology, Journal, Source Type: news

Surgical Approach Not Tied to Decision Regret After Prostatectomy
TUESDAY, March 3, 2020 -- Surgical approach is not associated with intermediate-term decision regret following radical prostatectomy, according to a study published in the March issue of The Journal of Urology. Martin Baunacke, M.D., from Technische... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 3, 2020 Category: Pharmaceuticals Source Type: news

Low Rates of Regret After Prostatectomy When Outcomes Are Good Low Rates of Regret After Prostatectomy When Outcomes Are Good
Patients are satisfied after either open or robot-assisted surgery, provided functional outcomes are good, an observational study reports.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 20, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Minimally Invasive Surgery Through the Eyes of a Surgeon
One of the best parts of an event like MD&M West is the opportunity to put a cross-section of experts from industry in the same room as engineers and end-users and talk about the biggest trends in medical devices. One such discussion that took place here in Annaheim, CA on Tuesday included an expert robotic surgeon, an expert from Intuitive Sugical (which, as you likely know by now, pioneered robotic surgery a little more than 20 years ago), and a new robotic surgery company that is trying to to take this technology beyond the surgical suite. I shared a few insights from this lively panel discussion here, but prior to...
Source: MDDI - February 11, 2020 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Janssen to Highlight Depth of Solid Tumor Portfolio at ASCO GU
RARITAN, N.J., February 3, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today multiple data presentations from a robust solid tumor portfolio that will be featured at the American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place February 13-15 in San Francisco. Company-sponsored data presentations will include clinical results for ERLEADA® (apalutamide) and niraparib in prostate cancer; and BALVERSA™ (erdafitinib) in bladder cancer. “We are committed to improving outcomes in patients with prostate and bladder cancer where high unmet...
Source: Johnson and Johnson - February 3, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Stress Urinary Incontinence Post-Prostatectomy May Lead to Pelvic Floor Overactivity
This study suggested that along with pelvic floor underactivity, men who had a prostatectomy and experienced stress urinary incontinence as a result have pelvic floor overactivity as well. (Source: CancerNetwork)
Source: CancerNetwork - January 28, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Tailored Pelvic PT May Curb Post-Prostatectomy Stress Incontinence, Pain Tailored Pelvic PT May Curb Post-Prostatectomy Stress Incontinence, Pain
After prostate surgery, individualized pelvic physical therapy to relax or strengthen the pelvic muscles may be more effective for reducing stress urinary incontinence (SUI) and pelvic pain than muscle strengthening alone, researchers suggest.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 13, 2020 Category: Consumer Health News Tags: Urology News Source Type: news

Prostate Cancer Treatment: Radical Prostatectomy Surgery
Title: Prostate Cancer Treatment: Radical Prostatectomy SurgeryCategory: Diseases and ConditionsCreated: 1/9/2020 12:00:00 AMLast Editorial Review: 1/9/2020 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - January 9, 2020 Category: Cancer & Oncology Source Type: news

Individualized PT Can Reduce Incontinence After Prostatectomy
FRIDAY, Jan. 3, 2020 -- For men with postprostatectomy stress urinary incontinence (SUI), an individualized pelvic physical therapy (PT) program aimed at normalizing pelvic floor dysfunction (PFD) is associated with a decrease in SUI and pelvic... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 3, 2020 Category: Pharmaceuticals Source Type: news

Prostate Cancer Genomic Classifier Appears Effective for Improved Patient Outcomes
When treatment decisions were made using a prostate genomic classifier after radical prostatectomy in men with prostate cancer, patient outcomes significantly improved. (Source: CancerNetwork)
Source: CancerNetwork - December 31, 2019 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

As & #039;Robot Wars & #039; Kick-In, Is Robotic Surgery Ripe for an & #039;iPhone Moment & #039;?
Is widespread adoption of surgical robots around the corner? The question is certainly timely given the recent developments in the sector. To name a few, in mid-September, CMR announced it raised $243 million in a Series C round, while reaching unicorn status. Two weeks later, Medtronic was unveiling Hugo to investors, its long-awaited robotic surgery system. Meanwhile, Verb Surgical, the joint venture between Johnson & Johnson and Verily, took on a new CEO ahead of market launch. As the range of offerings continue to expand, should we expect to see surgical robots in every OR soon? The answer is not quite yet. On one ...
Source: MDDI - December 4, 2019 Category: Medical Devices Authors: Michael Friedrich Tags: Design Source Type: news

Short-Term Androgen Suppression Improves PFS After Radical Prostatectomy for Prostate Cancer Short-Term Androgen Suppression Improves PFS After Radical Prostatectomy for Prostate Cancer
Short-term androgen deprivation therapy added to radiotherapy as salvage therapy after radical prostatectomy for prostate cancer improves 10-year progression-free survival, according to a follow-up of the GETUG-AFU 16 phase 3 trial.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 5, 2019 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Many Can Avoid RT After Surgery for Localized Prostate Cancer
WEDNESDAY, Oct. 9, 2019 -- Observation should be the standard approach after a prostatectomy for men with localized prostate cancer, with radiotherapy (RT) saved for if and when the cancer comes back, according to two studies presented at the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 9, 2019 Category: Pharmaceuticals Source Type: news

How to Survive Medtech & #039;s & #039;Death Valley & #039;
Medical device companies attempting to market a new treatment in the U.S. often make the erroneous assumption that winning FDA approval is the final destination, and success is theirs. In fact, going through the regulatory process is only the halfway point. The grueling path from FDA approval to reimbursement is like a treacherous walk through Death Valley and many companies don’t make it through. In this case study, I discuss the trials and triumphs of bringing robotic high intensity focused ultrasound (HIFU), a non-invasive procedure for localized prostate cancer, to the U.S.&Aci...
Source: MDDI - August 24, 2019 Category: Medical Devices Authors: Marc Oczachowski Tags: Regulatory and Compliance Business Source Type: news

Testosterone May Be Safe After Prostate Cancer Treatment Testosterone May Be Safe After Prostate Cancer Treatment
Studies show similar survival in men who used testosterone after radical prostatectomy or radiation therapy compared with those who did not.Medscape Urology (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - August 13, 2019 Category: Urology & Nephrology Tags: Urology Commentary Source Type: news

Adjuvant RT May Cut Recurrence in Some With Prostate Cancer
MONDAY, Aug. 12, 2019 -- Adjuvant radiotherapy after radical prostatectomy compared with surgery alone may prolong biochemical recurrence-free survival in patients with locally advanced prostate cancer, according to a study published online July 29... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2019 Category: Pharmaceuticals Source Type: news

Obesity Tied to Worse Perioperative Outcomes of Radical Prostatectomy Obesity Tied to Worse Perioperative Outcomes of Radical Prostatectomy
Obese men face higher odds of perioperative complications from radical prostatectomy, according to findings from a database study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - August 10, 2019 Category: Surgery Tags: Urology News Source Type: news

What is the Optimal PET/CT Approach for Assessing Recurrence of Prostate Cancer?
The study compared PET/CT tracers over  18F-fluciclovine when it comes to the localization of biochemical recurrence of prostate cancer following radical prostatectomy. (Source: CancerNetwork)
Source: CancerNetwork - August 7, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

New imaging method is more effective at detecting prostate cancer recurrence than standard scan
FINDINGSAfter prostate cancer surgery, it is important that patients are routinely screened for a recurrence of cancer. This screening is done with a blood test that checks for the presence of the prostate-specific antigen, or PSA. If this test comes back positive, it means that there is a recurrence of cancer. But this test doesn ’t indicate where the cancer is located.Doctors know that the location of recurring prostate cancer after surgery is often in the prostate fossa, the area where the prostate was before it was removed. But in some cases the cancer can be located outside of the prostate fossa, such as in the ...
Source: UCLA Newsroom: Health Sciences - August 1, 2019 Category: Universities & Medical Training Source Type: news

Using Patient-Reported Outcomes to Reflect Post-Prostatectomy Sexual Function
A new study used two patient-reported measures of sexual function following radical prostatectomy to assess sexual interest and satisfaction in men with prostate cancer. (Source: CancerNetwork)
Source: CancerNetwork - July 8, 2019 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news

Study shows more effective method for detecting prostate cancer
Each year, 1 million men in the U.S. undergo biopsies to determine whether they have prostate cancer. The biopsy procedure traditionally has been guided by ultrasound imaging, but this method cannot clearly display the location of tumors in the prostate gland.A multidisciplinary team of UCLA physicians has found that a new method, which includes biopsy guided by magnetic resonance imaging, or MRI, can be used together with the traditional method to increase the rate of prostate cancer detection.Ultrasound has been used to visualize the prostate in order to take a representative sampling of tissue to biopsy. The introductio...
Source: UCLA Newsroom: Health Sciences - June 13, 2019 Category: Universities & Medical Training Source Type: news

GETUG-AFU 16: Did Adding Hormonotherapy Improve 10-Year Outcomes in Prostate Cancer?
The researchers compared hormonotherapy plus radiotherapy vs radiotherapy alone in prostate cancer patients who previously underwent radical prostatectomy. (Source: CancerNetwork)
Source: CancerNetwork - June 1, 2019 Category: Cancer & Oncology Authors: Lauren M. Dembeck Source Type: news

Guidelines Updated for Radiotherapy After Prostatectomy
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 31, 2019 Category: Cancer & Oncology Tags: Oncology, Radiology, Surgery, Urology, Journal, Source Type: news

Guidelines Updated for Radiotherapy After Prostatectomy
FRIDAY, May 31, 2019 -- Clinical guidelines on adjuvant and salvage radiotherapy after radical prostatectomy have been updated, according to the American Society for Radiation Oncology and the American Urological Association. Ian Murchie Thompson,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 31, 2019 Category: Pharmaceuticals Source Type: news

AngioDynamics Sets Sights on Prostate Cancer with New IDE
FDA has given approval for AngioDynamics to undergo a pilot study of the NanoKnife for the ablation of prostate cancer tissue in low-risk patients. The IDE comes on the heels of the Latham, NY-based company making significant strides in its mission to obtain an indication for the treatment of pancreatic cancer. “NanoKnife has been in the market for a general soft tissue claim for about eight or nine years,” Brent Boucher, AngioDynamics, Senior VP and General Manager of Oncology, told MD+DI. “On April 1 we received approval to pursue a pancreas indication for stage three...
Source: MDDI - May 28, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

The prostate cancer conundrum: Should you opt for surgery — and risk nasty side-effects?
The National Institute for Health and Care Excellence said active surveillance should be considered an ‘equal choice’ to prostatectomy and radiotherapy for prostate cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - May 14, 2019 Category: Consumer Health News Source Type: news

Guidelines revised for rad therapy after prostatectomy
The American Society for Radiation Oncology and the American Urological Association...Read more on AuntMinnie.comRelated Reading: ASTRO: Prior authorization delays radiation treatment ASTRO hails new anti-self-referral legislation ASTRO updates radiation oncology safety guide Societies release guideline for localized prostate cancer Societies eye role for prostate MRI-guided biopsy ASTRO, AUA issue prostate radiation therapy guideline (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 2, 2019 Category: Radiology Source Type: news

ASTRO and AUA update joint clinical guidance for radiation therapy after prostatectomy
(American Society for Radiation Oncology) The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) today announced updates to their joint clinical guideline on adjuvant and salvage radiotherapy after prostatectomy in patients with and without evidence of prostate cancer recurrence to include new published research related to adjuvant radiotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 1, 2019 Category: Cancer & Oncology Source Type: news

End-to-Side Nerve Grafting Restores Erectile Function After Prostatectomy End-to-Side Nerve Grafting Restores Erectile Function After Prostatectomy
Microsurgical bilateral end-to-side nerve grafts can restore erectile function and improve sexual quality of life in men who have undergone radical prostatectomy, according to Australian researchers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 24, 2019 Category: Consumer Health News Tags: Urology News Source Type: news

UBC research recommends graduated return to work after prostatectomy
(University of British Columbia Okanagan campus) UBC research cautions men recovering from a radical prostatectomy to take it easy when returning to work. School of Nursing Professors Joan Bottorff and John Oliffe are scientists with UBC's Men's Health Research program. They, along with study lead Wellam Yu Ko, recently published research exploring the journey back into the workforce following surgery to remove prostate cancer. Their research concluded a graduated or 'reduced workload' program is the best option following a radical prostatectomy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 2, 2019 Category: Cancer & Oncology Source Type: news

Worry After Prostatectomy a Self-fulfilling Prophecy Worry After Prostatectomy a Self-fulfilling Prophecy
Three years after a radical prostatectomy, men with the personality trait of neuroticism scored worse on urinary, bowel, sexual, and hormonal domains.Medscape Medical News (Source: Medscape Urology Headlines)
Source: Medscape Urology Headlines - March 21, 2019 Category: Urology & Nephrology Tags: Hematology-Oncology News Source Type: news

Mauna Kea Nixes Deal with Cook Medical
Citing a lack of commercial progress, Mauna Kea Technologies is calling off an agreement with Cook Medical that was signed a little over three years ago involving Mauna Kea's Cellvizio platform. Paris, France-based Mauna Kea said the decision to terminate the development and distribution agreements with Cook was mutual. Cook has not officially commented on the news. Cellvizio is a multidisciplinary probe and needle-based confocal laser endoscopy platform. The device enables direct visualization of human tissues at the cellular scale and allows doctors to detect anomalies invisible with standard techniques, part...
Source: MDDI - February 21, 2019 Category: Medical Devices Authors: Amanda Pedersen Tags: Business Source Type: news

Mauna Kea, Cook Medical terminate Cellvizio dev, distro deal
Mauna Kea (ENT:MKEA) said today that it and Cook Medical have mutually decided to terminate their development and distribution agreement. The deal, originally inked in late 2015, included the development of Mauna Kea’s Cellvizio confocal laser endomicroscopy systems for urologic applications. Paris-based Mauna Kea said that it agreed to develop a private-label version of the Cellvizio with an emphasis on characterizing upper urinary tract urothelial cancer. “Mauna Kea was understandably excited by the prospect of combining our innovative, confocal laser endomicroscopy technology with an established medical...
Source: Mass Device - February 21, 2019 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Featured Imaging Urology Cook Medical Mauna Kea Technologies Source Type: news

What Is New in Robot-Assisted Radical Prostatectomy What Is New in Robot-Assisted Radical Prostatectomy
Get up-to-date on the latest advancements in the field of robot-assisted radical prostatectomy.Current Opinion in Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 14, 2019 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Surveillance of Low-Risk Prostate Cancer Tripled
(MedPage Today) -- Radical prostatectomy gained some ground for high-risk disease (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - February 12, 2019 Category: Hematology Source Type: news

Valve Surgery and Opioids; Hospital Alarm Fatigue: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics also include prostatectomy versus watchful waiting, and flu vaccines and heart failure (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - December 15, 2018 Category: Psychiatry Source Type: news

Does Radical Prostatectomy Trump Watchful Waiting? (CME/CE)
(MedPage Today) -- Randomized trial data point to benefit with surgery after 29 years, but much has changed over that time (Source: MedPage Today Surgery)
Source: MedPage Today Surgery - December 14, 2018 Category: Surgery Source Type: news

Radical Prostatectomy Has Lasting Benefit for Localized Cancer
THURSDAY, Dec. 13, 2018 -- Men with localized prostate cancer benefit from radical prostatectomy, with a mean of 2.9 years gained, according to a study published in the Dec. 13 issue of the New England Journal of Medicine. Anna Bill-Axelson, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2018 Category: Pharmaceuticals Source Type: news

Prostatectomy Beats Active Surveillance Long Term -- or Does It?
(MedPage Today) -- The 29-year follow-up makes data hard to interpret (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - December 13, 2018 Category: Hematology Source Type: news

Prostate Cancer: 3 Years More After Surgery Prostate Cancer: 3 Years More After Surgery
Men with clinically detected prostate cancer who had a long life expectancy lived for an additional 2.9 years following radical prostatectomy compared with patients who underwent watchful waiting.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 12, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Medical News Today: PSA levels after prostatectomy
A prostatectomy is one treatment option for prostate cancer. It involves the surgical removal of the prostate gland. Following a prostatectomy, doctors carry out regular prostate-specific antigen (PSA) testing to check that the cancer is not returning. Learn more about PSA after a prostatectomy here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 5, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news

Do Some Prostate Cancer Therapies Raise Patients ’ Risks for Bladder Cancer?
Treatment for prostate cancer with external beam radiotherapy was found to be associated with an increased risk for development of bladder cancer when compared with radical prostatectomy. (Source: CancerNetwork)
Source: CancerNetwork - October 19, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news